DC Field | Value | Language |
dc.contributor.author | Netrebenko, A. S. | - |
dc.contributor.author | Gureev, V. V. | - |
dc.contributor.author | Pokrovskii, M. V. | - |
dc.contributor.author | Gureeva, A. V. | - |
dc.contributor.author | Tsuverkalova, Y. M. | - |
dc.contributor.author | Rozhkov, I. S. | - |
dc.date.accessioned | 2023-03-02T06:46:01Z | - |
dc.date.available | 2023-03-02T06:46:01Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rat / A.S. Netrebenko [et al.] // Archives of Razi Institute. - 2021. - Vol.76, №4.-P. 995-1004. | ru |
dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/51944 | - |
dc.description.abstract | The present study aimed to investigate the protective effects of erythropoietin mimetic peptide (pHBSP) and infliximab on ischemic renal reperfusion injur. The experiment was performed on 70 white male Wistar laboratory rats which received recombinant erythropoietin, pHBSP, and infliximab | ru |
dc.language.iso | en | ru |
dc.subject | medicine | ru |
dc.subject | pharmacology | ru |
dc.subject | erythropoietin mimetic peptide (pHBSP) | ru |
dc.subject | infliximab | ru |
dc.subject | ischemia-reperfusion kidney injury | ru |
dc.subject | rats | ru |
dc.subject | microcirculation | ru |
dc.title | Assessment of the nephroprotective properties of the erythropoietin mimetic peptide and infliximab in kidney ischemia-reperfusion injury in rat | ru |
dc.type | Article | ru |
Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|